326 related articles for article (PubMed ID: 24915028)
1. [Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex].
Puertas-Martin V; Carreras-Saez I; Marana A; Ruiz-Falco Rojas ML; Cantarin-Extremera V; Calleja-Gero ML
Rev Neurol; 2014 Jun; 58(12):529-35. PubMed ID: 24915028
[TBL] [Abstract][Full Text] [Related]
2. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
[TBL] [Abstract][Full Text] [Related]
3. Epileptic spasms in tuberous sclerosis complex.
Hsieh DT; Jennesson MM; Thiele EA
Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
[TBL] [Abstract][Full Text] [Related]
6. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
[TBL] [Abstract][Full Text] [Related]
7. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
Mateos-González ME; López-Laso E; Vicente-Rueda J; Camino-León R; Fernández-Ramos JA; Baena-Gómez MA; Peña-Rosa MJ
Rev Neurol; 2014 Dec; 59(11):497-502. PubMed ID: 25418144
[TBL] [Abstract][Full Text] [Related]
8. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations.
Curatolo P; Jóźwiak S; Nabbout R;
Eur J Paediatr Neurol; 2012 Nov; 16(6):582-6. PubMed ID: 22695035
[TBL] [Abstract][Full Text] [Related]
9. Epilepsy in TSC: certain etiology does not mean certain prognosis.
Vignoli A; La Briola F; Turner K; Scornavacca G; Chiesa V; Zambrelli E; Piazzini A; Savini MN; Alfano RM; Canevini MP
Epilepsia; 2013 Dec; 54(12):2134-42. PubMed ID: 24304436
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study.
Saffari A; Brösse I; Wiemer-Kruel A; Wilken B; Kreuzaler P; Hahn A; Bernhard MK; van Tilburg CM; Hoffmann GF; Gorenflo M; Hethey S; Kaiser O; Kölker S; Wagner R; Witt O; Merkenschlager A; Möckel A; Roser T; Schlump JU; Serfling A; Spiegler J; Milde T; Ziegler A; Syrbe S
Orphanet J Rare Dis; 2019 May; 14(1):96. PubMed ID: 31053163
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine therapy of epilepsy in tuberous sclerosis.
Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
[TBL] [Abstract][Full Text] [Related]
12. [Tuberous sclerosis with infantile spasm and subependymal giant cell astrocytoma].
Yoneda T; Shimono M; Yoshino M; Takahashi Y
No To Hattatsu; 2016 Nov; 48(6):439-42. PubMed ID: 30010299
[TBL] [Abstract][Full Text] [Related]
13. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience.
Krueger DA; Capal JK; Curatolo P; Devinsky O; Ess K; Tzadok M; Koenig MK; Narayanan V; Ramos F; Jozwiak S; de Vries P; Jansen AC; Wong M; Mowat D; Lawson J; Bruns S; Franz DN;
Eur J Paediatr Neurol; 2018 Nov; 22(6):1066-1073. PubMed ID: 30005812
[TBL] [Abstract][Full Text] [Related]
14. [Neurosurgical aspects in the treatment of children with tuberous sclerosis complex].
Roth J; Fried I; Constantini S
Harefuah; 2014 Jan; 153(1):43-7, 63. PubMed ID: 24605407
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F
Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
[TBL] [Abstract][Full Text] [Related]
16. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN
Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174
[TBL] [Abstract][Full Text] [Related]
17. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.
Overwater IE; Rietman AB; Bindels-de Heus K; Looman CW; Rizopoulos D; Sibindi TM; Cherian PJ; Jansen FE; Moll HA; Elgersma Y; de Wit MC
Neurology; 2016 Sep; 87(10):1011-8. PubMed ID: 27511181
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment for localization-related infantile spasms: excellent long-term outcomes.
Yum MS; Ko TS; Lee JK; Hong S; Kim DS; Kim J
Clin Neurol Neurosurg; 2011 Apr; 113(3):213-7. PubMed ID: 21146918
[TBL] [Abstract][Full Text] [Related]
20. Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures.
Lechuga L; Franz DN
Expert Rev Neurother; 2019 Oct; 19(10):913-925. PubMed ID: 31335226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
